Phase 1B Study of Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Conditions: Autoimmune Diseases; Non-small Cell Lung Cancer; Rheumatoid Arthritis; Psoriasis; Giant Cell Arteritis; Polymyalgia Rheumatica; Systemic Lupus Erythematosus; Crohn Disease; Multiple Sclerosis; Ulcerative Colitis Intervention: Drug: Nivolumab Sponsors: Alliance Foundation Trials, LLC.; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arthritis | Autoimmune Disease | Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Psoriasis | Rheumatology | Study